Mol. Cells 2011; 31(5): 405-411
Published online April 8, 2011
https://doi.org/10.1007/s10059-011-0229-x
© The Korean Society for Molecular and Cellular Biology
Samil Jung, Lisha Yi, Jinsun Kim, Dongjun Jeong1, Taejeong Oh2, Chang-Hwan Kim1, Chang-Jin Kim1,
Jin Shin3, Sungwhan An2,*, and Myeong-Sok Lee*
Correspondence to : *Correspondence: mslee@sookmyung.ac.kr (MSL); sungwhan@genomictree.com (SA)
Multiple cytosine guanine dinucleotides (CpG island) are found in the VIM promoter region. The levels of VIM pro-moter methylation and VIM gene expression were investi-gated in 7 cervical cancer cell lines and 50 human tissue samples with a distinctive degree of malignant trans-for-mation. While multiple CpG sites in the VIM promoter were highly methylated in CIN III and invasive carcinoma cells, they were rarely methylated in normal cells. Our result shows that methylation in the VIM promoter appears to start from CIN I and CIN II, relatively early stages of multi-step carcinogenesis. This epigenetic alteration in VIM promoter suggests the availability as a biomarker for the early diagnosis and prevention of cervical cancer. We also show that hypermethylation in the VIM promoter is re-sponsible for transcriptional silencing of the VIM gene in cervical cancer cells. In addition, our result shows that exogenous overexpression of the VIM gene in SiHa cer-vical cancer cells slightly activated cell proliferation and migration as shown in soft agar colony formation and migration assays.
Keywords cervical cancer, epigenetic gene regulation, methylation biomarker, VIM
Mol. Cells 2011; 31(5): 405-411
Published online May 31, 2011 https://doi.org/10.1007/s10059-011-0229-x
Copyright © The Korean Society for Molecular and Cellular Biology.
Samil Jung, Lisha Yi, Jinsun Kim, Dongjun Jeong1, Taejeong Oh2, Chang-Hwan Kim1, Chang-Jin Kim1,
Jin Shin3, Sungwhan An2,*, and Myeong-Sok Lee*
Division of Biological Science and Research Center for Women’s Diseases, Sookmyung Women's University, Seoul 140-742, Korea, 1Department of Pathology, College of Medicine, Soonchunhyang University, Cheonan 330-090, Korea, 2Genomictree Inc., Daejeon 305-811, Korea, 3Songdo Technopark, Inchon 406-840, Korea
Correspondence to:*Correspondence: mslee@sookmyung.ac.kr (MSL); sungwhan@genomictree.com (SA)
Multiple cytosine guanine dinucleotides (CpG island) are found in the VIM promoter region. The levels of VIM pro-moter methylation and VIM gene expression were investi-gated in 7 cervical cancer cell lines and 50 human tissue samples with a distinctive degree of malignant trans-for-mation. While multiple CpG sites in the VIM promoter were highly methylated in CIN III and invasive carcinoma cells, they were rarely methylated in normal cells. Our result shows that methylation in the VIM promoter appears to start from CIN I and CIN II, relatively early stages of multi-step carcinogenesis. This epigenetic alteration in VIM promoter suggests the availability as a biomarker for the early diagnosis and prevention of cervical cancer. We also show that hypermethylation in the VIM promoter is re-sponsible for transcriptional silencing of the VIM gene in cervical cancer cells. In addition, our result shows that exogenous overexpression of the VIM gene in SiHa cer-vical cancer cells slightly activated cell proliferation and migration as shown in soft agar colony formation and migration assays.
Keywords: cervical cancer, epigenetic gene regulation, methylation biomarker, VIM
Min Jun Kim, Han Ju Lee, Mee Young Choi, Sang Soo Kang, Yoon Sook Kim, Jeong Kyu Shin, and Wan Sung Choi
Mol. Cells 2021; 44(3): 146-159 https://doi.org/10.14348/molcells.2021.0001Akhtar Ali, Sung Hwan Kim, Min Jun Kim, Mee Young Choi, Sang Soo Kang, Gyeong Jae Cho, Yoon Sook Kim, Jun-Young Choi, and Wan Sung Choi
Mol. Cells 2017; 40(7): 476-484 https://doi.org/10.14348/molcells.2017.2309Neoh Hun Phuah, Mohamad Nurul Azmi, Khalijah Awang, and Noor Hasima Nagoor
Mol. Cells 2017; 40(4): 291-298 https://doi.org/10.14348/molcells.2017.2285